Trial Outcomes & Findings for Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment (NCT NCT05618912)
NCT ID: NCT05618912
Last Updated: 2024-12-11
Results Overview
Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.
COMPLETED
NA
146 participants
7 days
2024-12-11
Participant Flow
Participant milestones
| Measure |
Hydrocolloid Dressing Arm
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Overall Study
STARTED
|
72
|
74
|
|
Overall Study
COMPLETED
|
58
|
55
|
|
Overall Study
NOT COMPLETED
|
14
|
19
|
Reasons for withdrawal
| Measure |
Hydrocolloid Dressing Arm
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
14
|
19
|
Baseline Characteristics
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Baseline characteristics by cohort
| Measure |
Hydrocolloid Dressing Arm
n=72 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=74 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
Total
n=146 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
63.8 years
STANDARD_DEVIATION 11.5 • n=5 Participants
|
61.3 years
STANDARD_DEVIATION 13.5 • n=7 Participants
|
61.9 years
STANDARD_DEVIATION 12.9 • n=5 Participants
|
|
Sex: Female, Male
Female
|
40 Participants
n=5 Participants
|
45 Participants
n=7 Participants
|
85 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
32 Participants
n=5 Participants
|
29 Participants
n=7 Participants
|
61 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
72 Participants
n=5 Participants
|
73 Participants
n=7 Participants
|
145 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 7 daysPopulation: The above numbers reflect the number of patients who responded at 7-day postoperative followup and is smaller than the original number of participants in each arm due to lack of response by some participants
Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.
Outcome measures
| Measure |
Hydrocolloid Dressing Arm
n=64 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=65 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Cosmetic Outcome
Surgeons - Scar Line
|
6.48 score on a scale
Standard Error 0.12
|
6.30 score on a scale
Standard Error 0.12
|
|
Cosmetic Outcome
Patients - Overall
|
7.4 score on a scale
Standard Error 2.0
|
6.6 score on a scale
Standard Error 1.9
|
|
Cosmetic Outcome
Surgeons - Overall
|
6.3 score on a scale
Standard Error 1.7
|
6.00 score on a scale
Standard Error 1.8
|
|
Cosmetic Outcome
Patients - Color
|
7.1 score on a scale
Standard Error 1.8
|
6.6 score on a scale
Standard Error 1.8
|
|
Cosmetic Outcome
Surgeons - Color
|
6.44 score on a scale
Standard Error 0.13
|
5.97 score on a scale
Standard Error 0.14
|
|
Cosmetic Outcome
Patients - Texture
|
6.8 score on a scale
Standard Error 2.0
|
6.4 score on a scale
Standard Error 2.0
|
|
Cosmetic Outcome
Surgeons - Texture
|
5.83 score on a scale
Standard Error 0.16
|
5.80 score on a scale
Standard Error 0.15
|
|
Cosmetic Outcome
Patients - Scar Line
|
7.0 score on a scale
Standard Error 2.1
|
6.4 score on a scale
Standard Error 2.1
|
PRIMARY outcome
Timeframe: 30 daysPopulation: The above numbers reflect the number of patients who responded at 30-day postoperative followup and is smaller than the original number of participants in each arm and the number of participants analyzed at 7-day followup due to lack of response by some participants
Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.
Outcome measures
| Measure |
Hydrocolloid Dressing Arm
n=64 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=60 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Cosmetic Outcome
Patients - Overall
|
7.6 score on a scale
Standard Error 1.5
|
7.6 score on a scale
Standard Error 1.9
|
|
Cosmetic Outcome
Surgeons - Overall
|
7.07 score on a scale
Standard Error 0.13
|
7.00 score on a scale
Standard Error 0.14
|
|
Cosmetic Outcome
Surgeons - Color
|
7.17 score on a scale
Standard Error 0.14
|
7.21 score on a scale
Standard Error 0.15
|
|
Cosmetic Outcome
Patients - Texture
|
7.0 score on a scale
Standard Error 1.6
|
6.4 score on a scale
Standard Error 2.1
|
|
Cosmetic Outcome
Surgeons - Texture
|
6.48 score on a scale
Standard Error 0.12
|
6.30 score on a scale
Standard Error 0.12
|
|
Cosmetic Outcome
Patients - Scar Line
|
7.3 score on a scale
Standard Error 1.7
|
7.3 score on a scale
Standard Error 2.1
|
|
Cosmetic Outcome
Surgeons - Scar Line
|
7.04 score on a scale
Standard Error 0.14
|
6.95 score on a scale
Standard Error 0.14
|
|
Cosmetic Outcome
Patients - Color
|
7.5 score on a scale
Standard Error 1.5
|
7.5 score on a scale
Standard Error 1.8
|
PRIMARY outcome
Timeframe: 90 daysPopulation: The above numbers reflect the number of patients who responded at 90-day postoperative followup and is smaller than the number of participants initially enrolled and the number analyzed at 7-day and 30-day followup due to lack of response by some participants
Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.
Outcome measures
| Measure |
Hydrocolloid Dressing Arm
n=58 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=55 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Cosmetic Outcome
Patients - Overall
|
8.2 score on a scale
Standard Error 1.8
|
8.1 score on a scale
Standard Error 1.6
|
|
Cosmetic Outcome
Surgeons - Color
|
6.44 score on a scale
Standard Error 0.13
|
5.97 score on a scale
Standard Error 0.14
|
|
Cosmetic Outcome
Patients - Texture
|
8.1 score on a scale
Standard Error 1.7
|
7.8 score on a scale
Standard Error 2.0
|
|
Cosmetic Outcome
Surgeons - Texture
|
8.28 score on a scale
Standard Error 0.11
|
8.14 score on a scale
Standard Error 0.12
|
|
Cosmetic Outcome
Patients - Scar Line
|
8.1 score on a scale
Standard Error 1.9
|
7.9 score on a scale
Standard Error 2.1
|
|
Cosmetic Outcome
Surgeons - Scar Line
|
7.89 score on a scale
Standard Error 0.13
|
7.86 score on a scale
Standard Error 0.13
|
|
Cosmetic Outcome
Surgeons - Overall
|
7.94 score on a scale
Standard Error 0.12
|
7.92 score on a scale
Standard Error 0.12
|
|
Cosmetic Outcome
Patients - Color
|
7.1 score on a scale
Standard Error 1.8
|
6.6 score on a scale
Standard Error 1.8
|
SECONDARY outcome
Timeframe: 7 days, 30 days, 90 daysComplication rate including hematoma, seroma, wound infection requiring antibiotics, opening and drainage of wound, dehiscence. Complications will be assessed by physicians other than operating surgeon
Outcome measures
| Measure |
Hydrocolloid Dressing Arm
n=72 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=74 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Number of Participants With Complications
Itching
|
29 Participants
|
28 Participants
|
|
Number of Participants With Complications
Surgical site pain
|
14 Participants
|
7 Participants
|
|
Number of Participants With Complications
Required antibiotics
|
0 Participants
|
0 Participants
|
|
Number of Participants With Complications
Wound dehiscence
|
4 Participants
|
0 Participants
|
|
Number of Participants With Complications
Post-op bleeding
|
13 Participants
|
5 Participants
|
Adverse Events
Hydrocolloid Dressing Arm
Petrolatum Jelly Dressing Arm
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Hydrocolloid Dressing Arm
n=72 participants at risk
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
|
Petrolatum Jelly Dressing Arm
n=74 participants at risk
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
|
|---|---|---|
|
Skin and subcutaneous tissue disorders
Itching
|
40.3%
29/72 • Number of events 29 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
37.8%
28/74 • Number of events 28 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
|
Skin and subcutaneous tissue disorders
Surgical site pain
|
19.4%
14/72 • Number of events 14 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
9.5%
7/74 • Number of events 7 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
|
Skin and subcutaneous tissue disorders
Required antibiotics
|
0.00%
0/72 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
0.00%
0/74 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
|
Skin and subcutaneous tissue disorders
Wound dehiscence
|
5.6%
4/72 • Number of events 4 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
0.00%
0/74 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
|
Skin and subcutaneous tissue disorders
Post-op bleeding
|
18.1%
13/72 • Number of events 13 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
6.8%
5/74 • Number of events 5 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
|
Additional Information
Dr. Syril Keena T. Que
Indiana University School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place